Fin Cascade
Get Android appGet iOS app

Prices as of 8 Oct 2026 close · Not investment advice

Kronox Lab Sciences Limited

NSE: KRONOXSpecialty ChemicalsTrade-to-trade true

Share price

₹200.60

-4.75% close of 8 Oct 2026

Market cap ₹742 CrP/E 26.0

Business score

How strong the business is, in one number. The parts behind it are in Pro.

61

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹742 Cr

P/E ratio

26.0

P/B ratio

6.4

ROCE

36.0%

ROE

27.2%

Dividend yield

0.2%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹217.0452-week low ₹97.02

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 6.1% over the past year, and 7.0% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 31.3% to 33.4% over the last two years.

Whether it grew faster than its sector

It grew 7.0% a year against a sector median of 10.2% — 3.1 percentage points slower.

Room to re-rate, or risk of de-rating

Too little price history yet to compare it with its own past.

Whether growth justifies the valuation

Priced at 1.4 times its growth rate, on earnings growth of 19%.

Profit growthPrice per ₹1 profitPer 1% growth
Kronox Lab Sciences Limited — this one19%/yr26.0×₹1.4
Gujarat Fluorochemicals Limited-24%/yr79.0×—
Navin Fluorine International Limited21%/yr53.0×₹2.5
Aether Industries Limited20%/yr96.7×₹4.8
Deepak Nitrite Limited-13%/yr27.0×—
Atul Limited9%/yr21.6×₹2.4

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Specialty Chemicals), it ranks 3 of 73 on returns, 52 of 72 on growth, 2 of 73 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

A wide advantage: it earns 36% on capital, ahead of 96% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹101 crore of cash from the business, spent ₹31 crore on plant and equipment, and returned ₹16 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 7 years, about 94 arrived as cash. Its cash comes back faster than it used to: it went from being waiting 122 days for its cash to waiting 71 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

8 of 8 checks clear · 100%

Latest result · Q4 FY26

What the last results showed. Whether management kept its word is in Pro.

Announced 13 Aug 2026 · Standalone · Audited

Revenue

₹26 Cr

Revenue vs last year

-0.0%

Revenue vs last quarter

+3.4%

Net profit

₹8 Cr

Profit vs last year

+26.6%

Profit vs last quarter

+21.4%

Net margin

30.6%

EPS

₹2.18

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹742 Cr
Prev close
₹200.60
52w High
₹228
52w Low
₹96.0
Enterprise value
₹695 Cr
Beta
1.2
Price CAGR 1y
37.0%
Price CAGR 3y
—
Price CAGR 5y
—
Price CAGR 10y
—

Ratios

Return on assets
21.9%
PEG ratio
1.4
P/E ratio
26.0
P/B ratio
6.4
EV / EBITDA
19.8
Industry P/E
32.7
ROCE
36.0%
ROCE 5y average
46.6%
ROE
27.2%
Debt / Equity
0.0
Interest coverage
—
Dividend yield
0.2%
ROE 3y average
31.0%
ROE last year
27.0%

Annual P&L

Annual revenue
₹101 Cr
Annual profit
₹28 Cr
Operating margin
34.0%
Net profit margin
27.7%
EBITDA margin
33.7%
Sales growth 3y
1.7%
Sales growth 5y
10.3%
Profit growth 3y
19.0%
Profit growth 5y
23.0%
EPS
₹7.5
Sales growth TTM
6.0%
Profit growth TTM
12.0%
Dividend payout
7.0%

Quarter P&L

Sales latest quarter
₹28 Cr
Profit latest quarter
₹7 Cr
YoY quarterly sales growth
16.9%
YoY quarterly profit growth
16.2%
OPM latest quarter
31.7%

Balance Sheet

Book Value
₹31.4
Face Value
₹10.0
Total debt
₹2 Cr
Total cash
₹49 Cr
Borrowings
₹2 Cr
Reserves / Equity
2.1

Cash Flow

Operating cash flow
₹24 Cr
Free cash flow
₹21 Cr
FCF yield
2.8%
Net cash flow
₹0 Cr

Shareholding

Promoter holding
74.2%
FII holding
0.0%
DII holding
2.1%
Public holding
23.7%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Pidilite Inds.1,483.8057.01,51,1310.77883.528.24,551.621.331.0
Gujarat Fluoroch4,562.0081.150,1140.07219.021.41,588.024.09.6
Navin Fluo.Intl.8,497.3554.843,6040.18243.3107.71,045.144.121.0
Aether Industri.1,778.0098.323,5990.0062.828.0326.627.311.9
Deepak Nitrite1,596.0027.521,7680.46345.0207.52,577.636.411.4
Aarti Industries493.5034.317,9010.20155.0256.52,387.042.56.9
Atul5,971.5022.117,5810.50253.992.01,848.025.014.9
Kronox Lab219.8028.68160.237.316.228.416.936.0
Median361.2728.61,0520.2313.552.5174.426.814.0

Competes with: Aarti Industries Limited, Aether Industries Limited, Atul Limited, BASF India Limited, Deepak Nitrite Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Pidilite Industries

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Standalone · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales26212122252524262426252628
Expenses17151514171616181617171719
Material Cost131310131115
Change in Inventories1.42-1.121.15-0.840.36-1.11
Purchases of Stock-in-Trade000000
Employee Cost1.241.781.842.141.641.93
Other Expenses2.762.783.683.253.263.48
Operating Profit8.525.866.087.858.218.808.367.757.978.658.039.528.99
OPM %33282935333535303334323632
Other Income0.240.490.020.830.430.360.820.910.871.041.132.151.30
Exceptional items (within Other Income)000000
Interest0000000000.040.040.040.03
Depreciation0.320.380.300.290.330.340.360.350.400.470.520.660.45
Profit before tax8.445.975.808.398.318.828.828.318.449.188.60119.81
Tax %25271830262726242627232726
Net Profit6.384.354.745.886.156.476.536.326.286.686.5987.30
EPS in Rs1.721.171.281.581.661.741.761.701.691.801.782.161.97
Diluted EPS in Rs1.721.701.821.792.182

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Standalone · to 31 Mar 2026
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5062829690100101105
Expenses3948637462676770
Material Cost4947
Change in Inventories2.25-0.56
Purchases of Stock-in-Trade00
Employee Cost4.757.40
Other Expenses1113
Operating Profit1215202228333435
OPM %2324242332333433
Other Income11122356
Exceptional items (within Other Income)00
Interest0000000.110
Depreciation12221.291.382.052
Profit before tax1213182229343739
Tax %27262626252626
Net Profit910141621252829
EPS in Rs3444045664.425.756.867.457.71
Diluted EPS in Rs6.917.51
Dividend Payout %0000977

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
—
5 years
10%
3 years
2%
TTM
6%

Compounded profit growth

10 years
—
5 years
23%
3 years
19%
TTM
12%

Stock price CAGR

10 years
—
5 years
—
3 years
—
1 year
37%

Return on equity

10 years
—
5 years
33%
3 years
31%
Last year
27%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Standalone
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.250.240.2437373737
Reserves2327408295379
Borrowings0430002
Other Liabilities1171398910
Total Liabilities343857547499128
Fixed Assets691116262829
CWIP0000011
Investments0000000
Other Assets29284538477098
Total Assets343857547499128

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Standalone
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity411920173124
Cash from Investing Activity-4-3-8-7-17-28-24
Cash from Financing Activity-0-7-1-130-2-0
Net Cash Flow011-000-0
Free Cash Flow31051152821

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Standalone
Line itemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1109011471727276
Inventory Days70585861744766
Days Payable102698952515452
Cash Conversion Cycle78798480946690
Working Capital Days10095122831436571
ROCE %505150524436

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Standalone · to 30 Jun 2026
Line itemJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters747474747474747474
FIIs1.560.560.490.050.030.030.050.080.04
DIIs4.342.572.202.201.711.9322.052.07
Public202323242424242424
No. of Shareholders32,60439,79238,48937,92237,56935,78034,60833,46932,479

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year +32.8% (₹151.03 → ₹200.60)Brick size ₹12.07 (fixed)Bricks 16
₹100₹150₹201Jan '26Jun '26
Price moved up one brickPrice moved down one brickLast close ₹200.60 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

-46.74inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

News

News and filings about Kronox Lab Sciences Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • acetic acid
  • citric acid
  • phosphoric acid
  • potassium carbonate
  • potassium hydroxide
  • soda ash
  • sodium bicarbonate
  • sodium hydroxide

Depends on the price of

  • caustic_soda
  • soda_ash

Sells to

  • Agrochemical formulators · ingredients in agrochemical formulations
  • Metal refineries · refining agents for metal refining
  • Nutraceutical formulators · ingredients for nutraceutical formulations (FCC grade)

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Specialty Chemicals
Classification
Chemicals › Specialty Chemicals
ISIN
INE0ATZ01017

Plants

  • Kronox Unit I
  • Kronox Unit II
  • Kronox Unit III
  • Proposed Unit IV, GIDC Dahej-II

News impact

Big market events that reach Kronox Lab Sciences Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

9 Sep 2026unspecified₹0.5
8 Aug 2025unspecified₹0.5
23 Aug 2024unspecified₹0.5

Splits, bonuses & buybacks

  • daily-prices repair: 2 rows from NSE's archive (replace 1, delete 0, insert 1), 2025-03-18..2026-02-01 (docs/flat_day_repair.md)1× · 18 Mar 2025

Bulk & block deals

DateWhoBought / soldSharesPrice
21 Aug 2026NK SECURITIES RESEARCH PRIVATE LIMITEDSELL10,10,563₹211.05
21 Aug 2026NK SECURITIES RESEARCH PRIVATE LIMITEDBUY10,10,563₹210.92
21 Aug 2026MICROCURVES TRADING PRIVATE LIMITEDSELL9,10,038₹209.65
21 Aug 2026MICROCURVES TRADING PRIVATE LIMITEDBUY9,10,038₹209.54
21 Aug 2026JUNOMONETA FINSOL PRIVATE LIMITEDBUY7,91,172₹209.22
21 Aug 2026JUNOMONETA FINSOL PRIVATE LIMITEDSELL7,72,632₹209.32
21 Aug 2026ALPHAGREP SECURITIES PRIVATE LIMITEDSELL6,65,501₹207.37
21 Aug 2026ALPHAGREP SECURITIES PRIVATE LIMITEDBUY6,65,501₹207.29
21 Aug 2026QE SECURITIES LLPSELL6,27,218₹206.74
21 Aug 2026QE SECURITIES LLPBUY6,22,248₹206.81

Insider trades

DisclosedWhoTypeSharesValue ₹ Cr
1 Oct 2026Mr. Ketan Ramani · PromoterSELL85,66,40088.42
1 Oct 2026Mr. Jogindersingh Jaswal · PromoterSELL85,66,40088.42
1 Oct 2026Mr. Pritesh Ramani · PromoterSELL67,11,20069.27

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.